BACKGROUND: Programs to prevent mother-to-child HIV transmission are plagued by loss to follow-up (LTFU) of HIV-exposed infants. We assessed if providing combination antiretroviral therapy (cART) to HIV-infected mothers was associated with reduced LTFU of their HIV-exposed infants in Kinshasa, DR Congo. METHODS: We constructed a cohort of mother-infant pairs using routinely collected clinical data. Maternal cART eligibility was based on national guidelines in effect at the time. Infants were considered LTFU after 3 failed tracking attempts after a missed visit or if more than 6 months passed since they were last seen in clinic. Statistical methods accounted for competing risks (eg, death). RESULTS: A total of 1318 infants enrolled at a median age of 2.6 weeks (interquartile range: 2.1-6.9), at which point 24% of mothers were receiving cART. Overall, 5% of infants never returned to care after enrollment and 18% were LTFU by 18 months. The 18-month cumulative incidence of LTFU was 8% among infants whose mothers initiated cART by infant enrollment and 20% among infants whose mothers were not yet on cART. Adjusted for baseline factors, infants whose mothers were not on cART were over twice as likely to be LTFU, with a subdistribution hazard ratio of 2.75 (95% confidence limit: 1.81 to 4.16). The association remained strong regardless of maternal CD4 count at infant enrollment. CONCLUSIONS: Increasing access to cART for pregnant women could improve retention of HIV-exposed infants, thereby increasing the clinical and population-level impacts of prevention of mother-to-child HIV transmission interventions and access to early cART for HIV-infected infants.
BACKGROUND: Programs to prevent mother-to-child HIV transmission are plagued by loss to follow-up (LTFU) of HIV-exposed infants. We assessed if providing combination antiretroviral therapy (cART) to HIV-infected mothers was associated with reduced LTFU of their HIV-exposed infants in Kinshasa, DR Congo. METHODS: We constructed a cohort of mother-infant pairs using routinely collected clinical data. Maternal cART eligibility was based on national guidelines in effect at the time. Infants were considered LTFU after 3 failed tracking attempts after a missed visit or if more than 6 months passed since they were last seen in clinic. Statistical methods accounted for competing risks (eg, death). RESULTS: A total of 1318 infants enrolled at a median age of 2.6 weeks (interquartile range: 2.1-6.9), at which point 24% of mothers were receiving cART. Overall, 5% of infants never returned to care after enrollment and 18% were LTFU by 18 months. The 18-month cumulative incidence of LTFU was 8% among infants whose mothers initiated cART by infant enrollment and 20% among infants whose mothers were not yet on cART. Adjusted for baseline factors, infants whose mothers were not on cART were over twice as likely to be LTFU, with a subdistribution hazard ratio of 2.75 (95% confidence limit: 1.81 to 4.16). The association remained strong regardless of maternal CD4 count at infant enrollment. CONCLUSIONS: Increasing access to cART for pregnant women could improve retention of HIV-exposed infants, thereby increasing the clinical and population-level impacts of prevention of mother-to-child HIV transmission interventions and access to early cART for HIV-infectedinfants.
Authors: Philip J Ciampa; José A Tique; Nilton Jumá; Mohsin Sidat; Troy D Moon; Russell L Rothman; Sten H Vermund Journal: J Acquir Immune Defic Syndr Date: 2012-06-01 Impact factor: 3.731
Authors: Thomas M Painter; Kassamba L Diaby; Danielle M Matia; Lillian S Lin; Toussaint S Sibailly; Moïse K Kouassi; Ehounou R Ekpini; Thierry H Roels; Stefan Z Wiktor Journal: BMJ Date: 2004-09-04
Authors: Rebecca E Cook; Philip J Ciampa; Mohsin Sidat; Meridith Blevins; Janeen Burlison; Mario A Davidson; Jorge A Arroz; Alfredo E Vergara; Sten H Vermund; Troy D Moon Journal: J Acquir Immune Defic Syndr Date: 2011-04 Impact factor: 3.771
Authors: Blake M Hauser; William C Miller; Hannock Tweya; Colin Speight; Tiwonge Mtande; Sam Phiri; L M Ball; Mina C Hosseinipour; Irving F Hoffman; Nora E Rosenberg Journal: Int J STD AIDS Date: 2017-07-27 Impact factor: 1.359
Authors: Gulzar H Shah; Gina D Etheredge; Jessica S Schwind; Lievain Maluantesa; Kristie C Waterfield; Astrid Mulenga; Osaremhen Ikhile; Elodie Engetele; Elizabeth Ayangunna Journal: Healthcare (Basel) Date: 2022-08-12
Authors: Gulzar H Shah; Gina D Etheredge; Lievain Maluentesa Nkuta; Kristie C Waterfield; Osaremhen Ikhile; John Ditekemena; Bossiky Ngoy Belly Bernard Journal: Trop Med Infect Dis Date: 2022-09-05
Authors: Andreas D Haas; Joep J van Oosterhout; Lyson Tenthani; Andreas Jahn; Marcel Zwahlen; Malango T Msukwa; Mary-Ann Davies; Kali Tal; Nozgechi Phiri; Adrian Spoerri; Frank Chimbwandira; Matthias Egger; Olivia Keiser Journal: J Int AIDS Soc Date: 2017-09-04 Impact factor: 5.396